• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因造血细胞移植受者的感染并发症:移植相关危险因素的回顾与当前预防策略。

Infectious complications in allogeneic hematopoietic cell transplant recipients: Review of transplant-related risk factors and current state of prophylaxis.

机构信息

Department of Bone Marrow Transplantation, National Hematology Research Center, Moscow, Russian Federation.

出版信息

Clin Transplant. 2021 Feb;35(2):e14172. doi: 10.1111/ctr.14172. Epub 2020 Dec 12.

DOI:10.1111/ctr.14172
PMID:33247497
Abstract

Allogeneic hematopoietic cell transplantation is a complex procedure that carries a significant risk of complications. Infections are among the most common of them. Several direct factors such as neutropenia, hypogammaglobulinemia, lymphopenia, mucosal barrier injury, and graft-versus-host disease have been shown to be associated with increased infectious risk post-transplant. Apart from direct factors, there are also indirect transplant-related factors that are the primary trigger to the formers' development. The most important of them are type of preparative regimen, graft source, donor type, graft-versus-host disease prophylaxis, and graft manipulation techniques. In this review, an attempt has been made to summarize the role of the transplant-related factors in the development of infectious complications and provide evidence underlying the current concept of infectious disease prophylaxis in patients after allogeneic hematopoietic cell transplantation.

摘要

异基因造血细胞移植是一种复杂的程序,有发生并发症的重大风险。感染是最常见的并发症之一。多项直接因素,如中性粒细胞减少、低丙种球蛋白血症、淋巴细胞减少、黏膜屏障损伤和移植物抗宿主病,已被证明与移植后感染风险增加有关。除了直接因素外,还有间接的移植相关因素,它们是导致前者发展的主要原因。其中最重要的是预处理方案的类型、移植物来源、供者类型、移植物抗宿主病预防和移植物处理技术。在这篇综述中,我们试图总结移植相关因素在感染并发症发展中的作用,并为异基因造血细胞移植后患者感染性疾病预防的现有概念提供依据。

相似文献

1
Infectious complications in allogeneic hematopoietic cell transplant recipients: Review of transplant-related risk factors and current state of prophylaxis.异基因造血细胞移植受者的感染并发症:移植相关危险因素的回顾与当前预防策略。
Clin Transplant. 2021 Feb;35(2):e14172. doi: 10.1111/ctr.14172. Epub 2020 Dec 12.
2
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
3
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.一项比较环孢素/甲氨蝶呤与他克莫司/西罗莫司作为异基因造血干细胞移植后移植物抗宿主病预防措施的前瞻性随机试验。
Haematologica. 2016 Nov;101(11):1417-1425. doi: 10.3324/haematol.2016.149294. Epub 2016 Aug 4.
4
Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant.异基因造血干细胞移植中含利妥昔单抗预处理方案的移植物抗宿主病风险
J Oncol Pharm Pract. 2017 Jun;23(4):255-263. doi: 10.1177/1078155216637216. Epub 2016 Mar 11.
5
Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.异基因造血干细胞移植受者与寄生虫病:临床病例文献综述及筛查与随访活动性和潜伏性慢性感染的展望
Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12669. Epub 2017 Mar 31.
6
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.低剂量抗胸腺细胞球蛋白预防亲缘全相合异基因造血干细胞移植后移植物抗宿主病
Biol Blood Marrow Transplant. 2017 Dec;23(12):2096-2101. doi: 10.1016/j.bbmt.2017.08.007. Epub 2017 Aug 15.
7
Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint.供者类型和疾病风险预测异基因造血细胞移植的成功:采用改良复合终点对 613 例成人造血细胞移植受者的单中心分析。
Biol Blood Marrow Transplant. 2017 Dec;23(12):2192-2198. doi: 10.1016/j.bbmt.2017.08.030. Epub 2017 Aug 30.
8
Risk factors for cefepime nonsusceptible Gram-negative infections in allogeneic hematopoietic cell transplant recipients.异基因造血细胞移植受者中头孢吡肟不敏感革兰阴性菌感染的危险因素。
J Oncol Pharm Pract. 2019 Mar;25(2):279-288. doi: 10.1177/1078155217731507. Epub 2017 Sep 26.
9
Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxis.造血干细胞移植与 HLA 不匹配供体:供体、来源、预处理和移植物抗宿主病预防的影响。
Expert Rev Hematol. 2019 Jan;12(1):47-60. doi: 10.1080/17474086.2019.1562331. Epub 2018 Dec 29.
10
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant.移植后环磷酰胺与抗胸腺细胞球蛋白在单倍体移植中预防移植物抗宿主病的比较
Haematologica. 2017 Feb;102(2):401-410. doi: 10.3324/haematol.2016.151779. Epub 2016 Oct 6.

引用本文的文献

1
Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation.造血干细胞移植前针对高优先级多重耐药病原体的移植前筛查对植入前感染的有效性
Infect Drug Resist. 2024 Jun 4;17:2249-2260. doi: 10.2147/IDR.S463868. eCollection 2024.
2
Post-engraftment Bloodstream Infections After Allogeneic Hematopoietic Cell Transplantation: Risk Factors and Association with Mortality.异基因造血细胞移植后植入后血流感染:危险因素及与死亡率的关联
Infect Chemother. 2023 Jun;55(2):204-213. doi: 10.3947/ic.2022.0146. Epub 2023 Mar 9.
3
Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology Patients.
造血干细胞移植和肿瘤患者抗菌药物管理中的挑战与机遇
Antibiotics (Basel). 2023 Mar 16;12(3):592. doi: 10.3390/antibiotics12030592.
4
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol).血液系统恶性肿瘤异基因干细胞移植后感染并发症监测、预防及治疗创新方案(BATMO方案)的结果
Front Oncol. 2022 Jun 17;12:874117. doi: 10.3389/fonc.2022.874117. eCollection 2022.
5
Clinical Manifestations of Pulmonary Mucormycosis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A 21-Case Series Report and Literature Review.异基因造血干细胞移植受者肺部毛霉菌病的临床特征:21 例系列报告及文献复习。
Can Respir J. 2022 Jun 2;2022:1237125. doi: 10.1155/2022/1237125. eCollection 2022.
6
Central nervous system infection with Seoul Orthohantavirus in a child after hematopoietic stem cell transplantation: a case report.儿童造血干细胞移植后感染首尔正粘病毒引起的中枢神经系统感染:病例报告。
Virol J. 2022 Apr 22;19(1):75. doi: 10.1186/s12985-022-01766-6.